Drawing for CAPNOPHARM

USPTO serial 79269046

CAPNOPHARM

Reviewed by CopyMark Law Group

Reg. 6126980Status 708Renewal
Filing date
Status date
Registration date
Aug 18, 2020
Examiner
BLAZICH, JOAN MICHELE
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with CAPNOPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John J. Arnott

John J. Arnott Munck Wilson Mandala, LLP2000 McKinney Ave., Ste. 1900Dallas, TX 75201United States

Goods and services

ClassDescriptionStatusFirst use
005[ Medicines and drugs for use in oncology and for the prevention and treatment of immune system related diseases and disorders; Medicines and drugs, namely, analgesic preparations, medical and pharmaceutical preparations and substances for treatments in the field of oncology and palliative medicine, namely, pharmaceutical preparations for use in oncology ]SECTION 71 - CANCELLED—
010Medical apparatus, instruments and tools in the nature of surgical apparatus, instruments and tools for minimally invasive surgery, trocars, medical tubes and air hoses for applying medical substances during minimally invasive surgery and automatic valves being structural parts for the aforesaid medical apparatus; metering pumps and injectors for administering medicines in aerosol form in measured amounts for medical purposes; structural components and accessories for aforesaid goodsACTIVE—
042Medical and pharmaceutical research and development services; scientific research for medical purposes in the field of oncology and palliative medicineACTIVE—
044Medical consultancy in relation to medical apparatus, instruments and tools for minimally invasive surgery; medical services in relation to surgical procedures, minimally invasive surgical procedures, diagnosis, treatments and therapies in the field of oncology and palliative medicine; compilation of medical treatments and therapies, namely, providing of medical information in the field of oncology and palliative care; medical counseling in relation to aforesaid medical services; rental of medical apparatus, instruments and tools for minimally invasive surgeryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 29, 2026C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jul 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 13, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Aug 18, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 18, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 30, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 7, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 7, 2020FIMPFINAL DISPOSITION PROCESSED—
Nov 18, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 12, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 27, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2020PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 28, 2020ALIEASSIGNED TO LIE—
Apr 22, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 20, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 22, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 5, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 5, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 20, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 14, 2019DOCKASSIGNED TO EXAMINER—
Oct 11, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance